|
|
|
GMOs at INRA
A field trial on genetically-modified grapevine rootstock at the INRA research centre in Colmar has attracted media attention due to vandalism of the site in 2009 and 2010 and the legal aftermath of these actions. This scientific project – exclusively aimed at furthering knowledge and in no way commercial – is noteworthy for other reasons however. It is the result of a lengthy collaborative process and ongoing dialogue between researchers, viticulture professionals and civil society via a monitoring committee. In an article published by PloS Biology, this committee, together with INRA scientists, review eight years of collaborative work to demonstrate that moving beyond anti- and pro-GMO controversy is possible.
|
| |
| |
> Science and society: from consultation to the interactive construction of research
While in the current context INRA does not intend to make available GM plant varieties for sale in France, the Institute strives to remain a major player in the field of plant biotechnologies. Around the world, plant biotechnologies, including GMOs, are a focus of research and innovation. INRA must insure its expertise in this field to contribute to decisions regarding potential requests to market GMOs in Europe; requests which are made by multinationals based on agronomic conditions different to those found on the European market. Through the quality of its research and expertise, INRA must therefore be able to assess the environmental, health, social and economic risks and benefits of these products.
> GMO: INRA must remain expert |
| |
| |
Label for the news :
News
Date for the news :
2011.03.08
Date of creation : 13/12/2010
Date of last update : 14/12/2010
|
|
|
|
